- PR Newswire•2 months ago
"The past year has been a period of transformational change for the company," said Michael F. Cola, President and Chief Executive Officer of Aevi Genomic Medicine. In conjunction with the corporate name change, the company will trade on the NASDAQ Global Market under the new ticker symbol "GNMX".
- Insider Monkey•2 months ago
You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain small-cap companies. However, well-known and successful hedge fund investors like Carl Icahn and George […]
- Marketwired•3 months ago
Medgenics, Inc. today announced that Michael F. Cola, President and Chief Executive Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference in New York, NY on Wednesday, November 30, ...
Requested symbol wasn't found
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|